CITADEL ADVISORS LLC

Q4 2024 13F-HR Detailed Holdings

Location
Miami, FL
Holdings as of
12/31/2024
Date filed
2/14/2025
Form type
13F-HR
Num holdings
17,346
Total value ($000)
$577,866,149
Net value change ($000)
+59,566,581 (11.5%)
New positions
1249
Sold out positions
964
Turnover %
7.3%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BA 941,765 2649.5%
AMZN 717,217 822.6%
AJG 674,362 8046.3%
UNH 666,769 502.5%
BAC 651,722 384.2%
EW 565,801 430.5%
CRM 539,615 6301.7%
DIS 528,587 2082.6%
META 461,971 200.3%
SBUX 433,514 2882.4%
Top Reduces (Value $000, Stocks/ETFs)
SPY -1,178,604 -54.1%
NVDA -444,811 -51.4%
C -418,407 -83.3%
SPOT -407,100 -100.0%
BSX -380,185 -46.3%
GS -307,165 -100.0%
PNC -303,345 -47.7%
TSLA -300,928 -78.5%
GEHC -294,666 -88.5%
ADBE -287,174 -68.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 469,668,344 (81.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Citadel Securities GP LLC 28-18870